Sagimet Biosciences Inc.

SGMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.18

+$0.38 (+3.52%)

Sep 22, 2026, 2:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $351.88M

Enterprise Value $113.7M

Beta 3.49

Average Volume 1.15M

Shares Outstanding (Diluted) 53.11M

Shares Change YoY 64.98%

Institutional Ownership 41.01%

Exchange NASDAQ

ISIN US7867001049

Price Performance

Price Change 1M 5.8%

Price Change 3M 53.0%

Price Change 6M 133.8%

Price Change YTD 80.3%

Price Change 1Y 58.6%

Price Change 3Y 11.0%

Price Change 5Y -32.3%

1M CAGR (ann.) 19.2%

1Y CAGR (ann.) 60.0%

5Y CAGR (ann.) N/A

All-Time CAGR -11.5%

Valuation

PE Ratio -8.44

Forward PE N/A

PEG Ratio -0.22

Forward PEG -0.41

PS Ratio N/A

Forward PS 48.00

PB Ratio 1.37

P/FCF Ratio -8.52

P/Adj. FCF Ratio -7.01

P/OCF Ratio -13.85

EV/Sales N/A

EV/EBIT -2.29

EV/EBITDA -2.29

EV/FCF -2.75

Earnings Yield -11.8%

FCF Yield -11.7%

Adj. FCF Yield -14.3%

Financial Health

Net Cash $240.13M

Total Debt $1.94M

Cash & Short-Term Investments $240.13M

Total Assets $263.43M

Current Ratio 45.02

Quick Ratio 45.02

Debt / Equity Ratio 0.01

Debt / EBITDA -0.04

Debt / FCF -0.05

OCF / Debt -21.30

Interest Coverage 0.00

Altman Z-Score 27.51

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -21.6%

Returns

Return on Assets -17.9%

Return on Equity -32.0%

Return on Invested Capital -20.4%

Return on Capital Employed -20.4%

Return on Tangible Assets -17.9%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y 0.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 0.0%

EPS CAGR 5Y -7.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y -23.5%

FCF CAGR 5Y -20.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 17.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.25

EPS Growth Est (next Q) -37.5%

Revenue Est (next Q) $166.67K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $18

Price Target Upside 66.7%

Cash Flow

Operating Cash Flow $-41.32M

Free Cash Flow $-41.32M

Adj. Free Cash Flow $-50.23M

FCF Per Share -$0.78

OCF Per Share -$0.78

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-52.63M

EBITDA $-49.7M

Net Income $-47.08M

EPS (Diluted) -$1.28

Revenue / Employee N/A

Profit / Employee $-2.94M

Employees 16